abiraterone,olaparib
astrazeneca,janssen,merck
['crpc', 'propel', 'olaparib', 'biomarker', 'marker ']
looking forward to fred saad, md, frcs #esmo22 presentation - biomarker analysis and updated results from the #propel trial of abi and olaparib vs abi and pbo as 1l therapy for pts with #mcrpc. written coverage to follow on urotoday! 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology